Target Ovarian Cancer’s My care, my future guide and our symptoms awareness campaign have both been awarded British Medical Association (BMA) Patient Information Awards. Target Ovarian Cancer is proud to TAKE OVAR and make sure we can be there for more women so they get the information they need, at the right time.
My care, my future was launched in May 2017 to inform and support women with incurable ovarian cancer, helping them think and talk about their diagnosis and the future. We are particularly delighted that the guide also received 'runner-up' in the special additional category of User Engagement.
Target Ovarian Cancer’s symptoms awareness campaign ran between July 2017 and February 2018 to provide clear and objective information about the symptoms of ovarian cancer and support and signposting for anyone worried about these symptoms, reaching over 250,000 people.
Lizzy Rodgers, Head of Information and Support at Target Ovarian Cancer, said:
We’re proud that our trusted ovarian cancer information has received such recognition at the BMA awards. Our symptoms awareness campaign is fundamental to our mission to ensure that all women know the symptoms of ovarian cancer, and our My care, my future guide provides support and information at what can be a difficult and isolating time. Contributions from healthcare professionals and women with ovarian cancer are vital in the development of information. We are grateful to all of the women and their families who shared their time and expertise with us and thrilled that some of them could join us on the day to receive the awards.
The BMA judges said of the My care, my future guide:
This is one of the best booklets on a medical topic I have ever read, particularly as it is for a group of patients who may not have the information they need. It is realistic but reassuring, and acknowledges they have a life to live. I think it fills a gap in the market, is well resourced and well-produced.
Additionally, the symptoms awareness campaign materials, including our symptoms film, were judged to be an "an exceptional suite of resources."
Annwen Jones, Chief Executive of Target Ovarian Cancer, said:
These are Target Ovarian Cancer’s sixth and seventh BMA awards respectively, and I’m incredibly proud of the continued hard work of our staff, working alongside women with ovarian cancer and clinical reviewers, to provide high-quality tailored information that we know makes a huge difference. Improving early diagnosis is essential to improving survival rates for ovarian cancer, and our symptoms awareness campaign is crucial if we are to ensure that all women are diagnosed at the earliest possible stage.